
APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
February 17th, 2022
APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
February 17th, 2022
Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2nd, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20th, 2020
For Applied DNA, New Blood — And A Shot In The Arm
August 14th, 2019
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12th, 2019
LineaRx Acquires Cancer Cell Analysis Firm Vitatex
August 9th, 2019
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8th, 2019
5-Year Agreement with Montblanc to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients
July 2nd, 2019
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1st, 2019